Dr. Besim Ogretmen of the Medical University of South Carolina recently discovered a Covid Biomarker through lipid research.
Dr. Ogretmen and his team typically focuses on cancer research, but they pivoted their efforts during the pandemic.
They discovered that a person’s level of lipid biomarker sphingosine had more than a 90% accuracy rate of determining if the person would have an asymptomatic or symptomatic case of covid-19.
He says the studies might also be useful to predict people who would still get covid-19 symptoms after vaccination with antibody and lipidomics detections.
In this interview Dr. Ogretmen shares information about his research, the discovery, as well as incredibly fascinating information about the field of Lipidomics – and how increased focus on the field could help transform medicine. He also says MUSC is a world-class Lipidomics center.
Dr. Besim Ogretmen is the Prof. Of Biochemistry,
Assoc. Dir. For Basic Sciences at the Hollings Cancer Center, and Assoc. Dean For Research at the College Of Medicine the Medical University of South Carolina.
Learn more about the Medical Univ. of South Carolina: https://muschealth.org
Learn more about the MUSC Children’s Hospital: https://musckids.org
Topical time codes:
00:00 – Interview starts
1:05 – Research findings
2:30 – Helping identify those most vulnerable to covid-19
4:12 – Determining how lipid biomarkers can help
6:43 – How Lipidomics could work together with genomics & help early disease detection
8:33 – About the sphingosine lipid
10:27 – Those with sphingosine levels above the normal range had better outcomes dealing with covid
11:49 – Ability of lipids to help with cardiovascular and other conditions, as well as medications
13:39 – Lipid research has many applications and is gaining attention
15:43 – Passion for research
19:04 – Desire to help during the pandemic
22:03 – Science is cumulative work, a collective community
